Cargando…

BIOMARKER STRATEGIES FOR GEROSCIENCE-GUIDED CLINICAL TRIALS

Significant progress in the biology of aging and animal models supports the geroscience hypothesis: by targeting biological aging the onset of age-related diseases can be delayed. Geroscience investigators will test this hypothesis in a multicenter clinical trial, to determine if interventions on bi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Justice, Jamie N, Kuchel, George A, Barzilai, Nir, Kritchevsky, Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Session 3440 (Symposium)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6841352/ http://dx.doi.org/10.1093/geroni/igz038.2731

Ejemplares similares

USING OBSERVATIONAL DATA TO INFORM CANDIDATE PHENOTYPES FOR GEROSCIENCE TRIALS
por: Sanders, Jason L, et al.
Publicado: (2019)

DEVELOPMENT OF EPIGENETIC MEASURES FOR GEROSCIENCE CLINICAL TRIALS
por: Levine, Morgan E
Publicado: (2019)

INTEREST GROUP SESSION—GEROSCIENCE: METHODS FROM BENCH TO POPULATION SCIENCE TO INFORM CONSTRUCTION OF GEROSCIENCE CLINICAL TRIALS
por: Sanders, Jason L, et al.
Publicado: (2019)

CELLULAR SENESCENCE AS A THERAPEUTIC TARGET FOR GEROSCIENCE-GUIDED CLINICAL TRIALS
por: Justice, Jamie N, et al.
Publicado: (2019)

CLINICAL TRIALS IN GEROSCIENCE
por: Kaeberlein, Matt, et al.
Publicado: (2019)

SENOLYTIC DRUGS: DISCOVERY, TRANSLATION, AND APPLICATION
por: LeBrasseur, Nathan
Publicado: (2019)

The Translational Geroscience Network: Supporting a New Paradigm to Alleviate Age-Related Chronic Disease
por: Justice, Jamie, et al.
Publicado: (2020)

A geroscience perspective on immune resilience and infectious diseases: a potential case for metformin
por: Justice, Jamie N., et al.
Publicado: (2020)

PRESIDENTIAL SYMPOSIUM: EXPANDING THE GEROSCIENCE NETWORK
por: Kaeberlein, Matt
Publicado: (2019)

EXPANDING THE NETWORK: NONTRADITIONAL ANIMAL MODELS IN GEROSCIENCE
por: Cohen, Alan A
Publicado: (2019)

BREAKING GROUND IN TRANSLATIONAL GEROSCIENCE: FROM BIOMARKERS TO CLINICAL TRIALS
por: Justice, Jamie
Publicado: (2022)

Geroscience‐guided repurposing of FDA‐approved drugs to target aging: A proposed process and prioritization
por: Kulkarni, Ameya S., et al.
Publicado: (2022)

Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age
por: Cummings, Steven R., et al.
Publicado: (2022)

The First Evaluation of a Geroscience Biomarker Index (TAME-BI) in a Trial of Caloric Restriction and Exercise
por: Justice, Jamie, et al.
Publicado: (2021)

Operationalizing Healthspan as an Outcome for Clinical Trials in Geroscience
por: Justice, Jamie
Publicado: (2021)

UPDATE IN GEROSCIENCE FOR NONBIOLOGISTS
por: Kuchel, George, et al.
Publicado: (2022)

Evaluating Health Span in Preclinical Models of Aging and Disease: Guidelines, Challenges, and Opportunities for Geroscience
por: Huffman, Derek M., et al.
Publicado: (2016)

Challenges in developing Geroscience trials
por: Rolland, Yves, et al.
Publicado: (2023)

Geroscience in the Age of COVID-19
por: Barzilai, Nir, et al.
Publicado: (2020)

INVESTIGATING DYNAMICS OF AGE-ASSOCIATED TRANSCRIPTIONAL NETWORKS WITH INTERVENTIONS TARGETING AGING
por: Kulkarni, Ameya S, et al.
Publicado: (2019)

SIGNIFICANT PUBLIC POLICY ISSUES IN THE HEALTH SCIENCES
por: Kritchevsky, Stephen
Publicado: (2019)

Putting epigenetic biomarkers to the test for clinical trials
por: Justice, Jamie N, et al.
Publicado: (2020)

PRESIDENTIAL SYMPOSIUM: MULTIDISCIPLINARY EMERGING PERSPECTIVES ON BUILDING AND MAINTAINING NETWORKS IN AGING.
por: Petrovsky, Darina V, et al.
Publicado: (2019)

ESPO AND NIA BUTLER-WILLIAMS SCIENTIFIC SYMPOSIUM: INFLUENCE OF RACE, ETHNICITY, AND EXPERIENCE ON HEALTH IN AGING
por: Justice, Jamie N, et al.
Publicado: (2019)

APOE2 AND AGING-RELATED OUTCOMES IN 261,000 UK BIOBANK OLDER ADULTS
por: Kuo, Chia-Ling, et al.
Publicado: (2019)

Network Topology of Biological Aging and Geroscience-Guided Approaches to COVID-19
por: Landay, Alan, et al.
Publicado: (2021)

ADDRESSING DEMENTIA CLINICAL SYMPTOMS USING NONPHARMACOLOGICAL STRATEGIES: WHAT WORKS AND FOR WHOM?
por: Gitlin, Laura N, et al.
Publicado: (2019)

OLDER WOMEN WITH HIV: STRATEGIES FOR HEALTHY AGING
por: Brennan-Ing, Mark, et al.
Publicado: (2019)

INNOVATIVE STRATEGIES TO SUPPORT OLDER ADULTS AND THEIR FAMILIES IN HOSPICE AND PALLIATIVE CARE
por: Demiris, George, et al.
Publicado: (2019)

CORRECTING GLUTATHIONE DEFICIENCY AND MITOCHONDRIAL DYSFUNCTION IN OLDER HUMANS: A RANDOMIZED CLINICAL TRIAL
por: Sekhar, Rajagopal V, et al.
Publicado: (2019)

INFORMED CONSENT IN CLINICAL TRIALS FOR PERSONS WITH DEMENTIA
por: Carpenter, Joan G
Publicado: (2019)

PROMOTING HEALTHY AGING THROUGH PRAGMATIC CLINICAL TRIALS
por: Chodosh, Joshua, et al.
Publicado: (2019)

OLDER ADULT FALLS PREVENTION: THREE ADOPTED CLINICAL STRATEGIES FROM EVALUATION OF THE CDC STEADI INITIATIVE
por: Edwards, Jennifer, et al.
Publicado: (2019)

BIOMARKERS OF SENESCENT CELL BURDEN
por: LeBrasseur, Nathan
Publicado: (2019)

NOVEL AGING BIOMARKERS IN THE HRS
por: Crimmins, Eileen
Publicado: (2019)

Computational tools for geroscience
por: Kruempel, Joseph C.P., et al.
Publicado: (2019)

MAKING ENGAGEMENT MEANINGFUL THROUGH ORGANIZED ROUTINE INTERACTION (MEMORI) CORPS TRIAL: AN INTRODUCTION
por: Samus, Quincy M, et al.
Publicado: (2019)

Geroscience approaches to obesity
por: Bitto, Alessandro, et al.
Publicado: (2021)

ROBUST BIOMARKERS OF AGING AND THEIR BIOLOGICAL ORIGIN
por: Podolskiy, Dmitriy, et al.
Publicado: (2019)

CONDUCTING CLINICAL TRIALS AMONG PERSONS WITH DEMENTIA: METHODS, CHALLENGES, AND OPPORTUNITIES FOR IMPROVEMENT
por: Sefcik, Justine S, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d27l5097o113lvkh2pjrcftj2n